|
|
Volumn 11, Issue 2, 2015, Pages 416-418
|
|
BCL2L11/Bim as a dual-agent regulating autophagy and apoptosis in drug resistance
|
|
Author keywords
Acquired drug resistance; Autophagy; BCL2L11 Bim; Multiple myeloma; Targeted therapy
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BCL2L11 PROTEIN;
BH3 PROTEIN;
BIM PROTEIN;
PROTEIN BCL 2;
PROTEIN BCL XL;
UNCLASSIFIED DRUG;
APOPTOSIS REGULATORY PROTEIN;
BCL2L11 PROTEIN, HUMAN;
MEMBRANE PROTEIN;
ONCOPROTEIN;
PROTEIN BCL X;
APOPTOSIS;
ARTICLE;
AUTOPHAGY;
CANCER CHEMOTHERAPY;
CANCER RESISTANCE;
CELL PROTECTION;
HUMAN;
NONHUMAN;
PROTEIN FAMILY;
REGULATORY MECHANISM;
TREATMENT RESPONSE;
DRUG EFFECTS;
DRUG RESISTANCE;
METABOLISM;
ANTINEOPLASTIC AGENTS;
APOPTOSIS;
APOPTOSIS REGULATORY PROTEINS;
AUTOPHAGY;
BCL-2-LIKE PROTEIN 11;
BCL-X PROTEIN;
DRUG RESISTANCE;
HUMANS;
MEMBRANE PROTEINS;
PROTO-ONCOGENE PROTEINS;
|
|
EID: 84954489247
PISSN: 15548627
EISSN: 15548635
Source Type: Journal
DOI: 10.1080/15548627.2014.998892 Document Type: Article |
|
Times cited : (50)
|
|
References (0)
|
